A Three-Dimensional Quantitative Structure-Activity Analysis of a New Class of Bisphenol Topoisomerase IIα Inhibitors

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Molecular Pharmacology

• Publication date

  2008-03-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1124/mol.107.041624
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Mechanism of Action

  2020influential reference
• A Three-Dimensional Quantitative Structure-Activity Relationship Study of the Inhibition of the ATPase Activity and the Strand Passing Catalytic Activity of Topoisomerase IIα by Substituted Purine Analogs

  2006cited by this paper
• A Structure-Based 3D-QSAR Study of Anthrapyrazole Analogues of the Anticancer Agents Losoxantrone and Piroxantrone

  2006cited by this paper
• The antitumor anthracyclines doxorubicin and daunorubicin do not inhibit cell growth through the formation of iron-mediated reactive oxygen species

  2005cited by this paper
• Structure-activity study of the interaction of bioreductive benzoquinone alkylating agents with DNA topoisomerase II

  2005cited by this paper
• Biochemical and Proteomics Approaches to Characterize Topoisomerase IIα Cysteines and DNA as Targets Responsible for Cisplatin-Induced Inhibition of Topoisomerase IIα

  2005cited by this paper
• Substituted purine analogues define a novel structural class of catalytic topoisomerase II inhibitors.

  2005influential reference
• Synthesis and characterization of the biological activity of the cisplatin analogs, cis-PtCl(2)(dexrazoxane) and cis-PtCl(2)(levrazoxane), of the topoisomerase II inhibitors dexrazoxane (ICRF-187) and levrazoxane (ICRF-186).

  2004cited by this paper
• Catalytic topoisomerase II inhibitors in cancer therapy.

  2003cited by this paper
• Structure of the topoisomerase II ATPase region and its mechanism of inhibition by the chemotherapeutic agent ICRF-187

  2003cited by this paper
• Enforced cytokinesis without complete nuclear division in embryonic cells depleting the activity of DNA topoisomerase IIα

  2003cited by this paper
• Stabilization of eukaryotic topoisomerase II-DNA cleavage complexes.

  2003cited by this paper
• Cellular roles of DNA topoisomerases: a molecular perspective

  2002cited by this paper
• Tumor cell death induced by topoisomerase-targeting drugs.

  2001influential reference
• Topoisomerase II-mediated cleavage of plasmid DNA.

  2001influential reference
• Exploiting anthracycline scaffold for designing DNA-targeting agents.

  2001influential reference
• Synthesis and Characterization of

  2001influential reference
• Topoisomerase II as a target for anticancer drugs: when enzymes stop being nice.

  2000influential reference
• A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin.

  1999cited by this paper
• Catalytic inhibitors of DNA topoisomerase II.

  1998cited by this paper
• Improved targeting of brain tumors using dexrazoxane rescue of topoisomerase II combined with supralethal doses of etoposide and teniposide.

  1998cited by this paper
• Three-dimensional quantitative similarity-activity relationships (3D QSiAR) from SEAL similarity matrices.

  1998cited by this paper
• Mechanism of action of eukaryotic DNA topoisomerase I and drugs targeted to the enzyme.

  1998influential reference
• DNA topoisomerase II rescue by catalytic inhibitors: a new strategy to improve the antitumor selectivity of etoposide.

  1997cited by this paper
• Characterization of a Chinese hamster ovary cell line with acquired resistance to the bisdioxopiperazine dexrazoxane (ICRF-187) catalytic inhibitor of topoisomerase II.

  1997cited by this paper
• Collateral sensitivity to the bisdioxopiperazine dexrazoxane (ICRF-187) in etoposide (VP-16)-resistant human leukemia K562 cells.

  1996cited by this paper
• The effect of dexrazoxane (ICRF-187) on doxorubicin- and daunorubicin-mediated growth inhibition of Chinese hamster ovary cells.

  1996cited by this paper
• A QSAR study comparing the cytotoxicity and DNA topoisomerase II inhibitory effects of bisdioxopiperazine analogs of ICRF-187 (dexrazoxane).

  1995cited by this paper
• Reduced phosphorylation of topoisomerase II in etoposide-resistant human leukemia K562 cells.

  1994cited by this paper
• Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity.

  1994cited by this paper
• Altered stability of etoposide-induced topoisomerase II-DNA complexes in resistant human leukaemia K562 cells.

  1994cited by this paper
• Antagonistic effect of the cardioprotector (+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane (ICRF-187) on DNA breaks and cytotoxicity induced by the topoisomerase II directed drugs daunorubicin and etoposide (VP-16).

  1993influential reference
• Inhibition of intracellular topoisomerase II by antitumor bis(2,6-dioxopiperazine) derivatives: mode of cell growth inhibition distinct from that of cleavable complex-forming type inhibitors.

  1991cited by this paper
• Inhibition of topoisomerase II by antitumor agents bis(2,6-dioxopiperazine) derivatives.

  1991cited by this paper
• A model for tumor cell killing by topoisomerase poisons.

  1990cited by this paper
• Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins.

  1988cited by this paper

• Top2a promotes the development of social behavior via PRC2 and H3K27me3

  2021cites this paper
• Molecular dynamics simulations of sulfone derivatives in complex with DNA topoisomerase IIα ATPase domain

  2020cites this paper
• Intermolecular Reductive Heck Reaction of Unactivated Aliphatic Alkenes with Organohalides.

  2020cites this paper
• Evaluation of Nitrobenzyl Derivatives of Camptothecin as Anti-Cancer Agents and Potential Hypoxia Targeting Prodrugs

  2018cites this paper
• Copper-Catalyzed Arylation of Benzylic C-H bonds with Alkylarenes as the Limiting Reagents.

  2017cites this paper
• Synthesis and biological activity of 2,4-di-p-phenolyl-6-2-furanyl-pyridine as a potent topoisomerase II poison.

  2015cites this paper
• Lewis‐Acid‐Catalysed Friedel–Crafts Alk­ylation of Donor–Acceptor Cyclopropanes with Electron‐Rich Benzenes to Generate 1,1‐Diarylalkanes

  2015cites this paper
• Synthesis, antitumor activity, and structure-activity relationship study of trihydroxylated 2,4,6-triphenyl pyridines as potent and selective topoisomerase II inhibitors.

  2014cites this paper
• Distinctive meta-directing group effect for iridium-catalyzed 1,1-diarylalkene enantioselective hydrogenation.

  2013cites this paper
• Pd(0)-catalyzed 1,1-diarylation of ethylene and allylic carbonates.

  2013cites this paper
• Ellagic acid and polyhydroxylated urolithins are potent catalytic inhibitors of human topoisomerase II: an in vitro study.

  2012cites this paper
• Dihydroxylated 2,4,6-triphenyl pyridines: synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study.

  2012cites this paper
• High-Throughput Screening Identifies a Bisphenol Inhibitor of SV40 Large T Antigen ATPase Activity

  2012cites this paper
• Design, synthesis, and biological evaluation of a novel series of bisintercalating DNA-binding piperazine-linked bisanthrapyrazole compounds as anticancer agents.

  2011cites this paper
• Integrating molecular docking, DFT and CoMFA/CoMSIA approaches for a series of naphthoquinone fused cyclic α-aminophosphonates that act as novel topoisomerase II inhibitors

  2011cites this paper
• A new approach to carbon-carbon bond formation: Development of aerobic Pd-catalyzed reductive coupling reactions of organometallic reagents and styrenes.

  2009cites this paper
• Palladium-catalyzed oxidative intermolecular difunctionalization of terminal alkenes with organostannanes and molecular oxygen.

  2009cites this paper
• Bisphénols utilisés dans le traitement du cancer

  2008cites this paper